| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.7M | — | +184.5% |
| R&D Expense | $4.3M | — | +46.9% |
| SG&A Expense | $72.2M | — | +75.7% |
| Operating Income | -$60.1M | — | -61.8% |
| Net Income | -$60.6M | — | -78.6% |
| EPS (Basic) | -$0.61 | — | -74.3% |
| EPS (Diluted) | -$0.61 | — | -74.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.3M | -41.1% | -39.0% |
| Short-term Investments | $176.6M | -13.3% | -25.1% |
| Accounts Receivable | $28.7M | +13.1% | +208.1% |
| Inventory | $32.0M | +2.0% | +340.7% |
| Current Assets | $245.2M | -13.9% | -19.3% |
| Total Assets | $287.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$44.9M | — | -10.3% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $27.8M | — | -4.4% |
| Financing Cash Flow | $159K | — | -78.1% |
| Free Cash Flow | -$44.9M | — | -10.1% |
| -12.1% |
| Current Liabilities | $49.6M | +26.7% | +79.6% |
| Long-term Debt | $96.5M | +0.2% | — |
| Total Liabilities | $226.3M | +6.0% | +130.1% |
| Stockholders' Equity | $61.3M | -46.3% | -73.2% |